Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S S Markin

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Biomeditsinskaia Khimiia|November 10, 2025
Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trialV V Kukharchuk, E A Ponomarenko, A V Lisitsa, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 9, 2026
[Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry]N A Shamalov, M Yu Martynov, E I Gusev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 5, 2026
[Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry]N A Shamalov, M Yu Martynov, E I Gusev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 15, 2026
[Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry]N A Shamalov, M Yu Martynov, N A Marskaya, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 29, 2022
[Nonimmunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results)]E I Gusev, M Yu Martynov, N A Shamalov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 12, 2026
[Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry]N A Shamalov, M Yu Martynov, E I Gusev, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Biomeditsinskaia Khimiia|November 10, 2025
Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trialV V Kukharchuk, E A Ponomarenko, A V Lisitsa, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 9, 2026
[Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry]N A Shamalov, M Yu Martynov, E I Gusev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 5, 2026
[Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry]N A Shamalov, M Yu Martynov, E I Gusev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 15, 2026
[Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry]N A Shamalov, M Yu Martynov, N A Marskaya, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 29, 2022
[Nonimmunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results)]E I Gusev, M Yu Martynov, N A Shamalov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 12, 2026
[Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry]N A Shamalov, M Yu Martynov, E I Gusev, et al.
Pageof 3